6,710
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials

, , , , ORCID Icon, , , , , , , & show all
Article: 2161812 | Received 08 Nov 2022, Accepted 19 Dec 2022, Published online: 23 Jan 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.